FERONE, DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 288
AS - Asia 108
EU - Europa 98
AF - Africa 3
SA - Sud America 2
Totale 499
Nazione #
US - Stati Uniti d'America 278
CN - Cina 56
SG - Singapore 46
SE - Svezia 23
IT - Italia 21
IE - Irlanda 14
FI - Finlandia 12
CA - Canada 10
NL - Olanda 10
RU - Federazione Russa 5
UA - Ucraina 4
CI - Costa d'Avorio 3
DE - Germania 3
BR - Brasile 2
CZ - Repubblica Ceca 2
FR - Francia 2
HK - Hong Kong 2
JP - Giappone 2
BE - Belgio 1
GB - Regno Unito 1
IN - India 1
TR - Turchia 1
Totale 499
Città #
Santa Clara 43
Singapore 37
Chandler 31
Millbury 23
Beijing 22
Princeton 18
Nanjing 15
Houston 13
Amsterdam 10
Des Moines 9
Ashburn 8
Ottawa 8
Wilmington 8
Jacksonville 6
Jiaxing 6
Boston 5
Milan 5
Napoli 5
Hebei 4
Ann Arbor 3
Casoria 3
Helsinki 3
Nanchang 3
Bari 2
Brno 2
Castel San Giorgio 2
Dublin 2
Iwata 2
Kunming 2
Romainville 2
Shenyang 2
Toronto 2
Woodbridge 2
Boardman 1
Brussels 1
Changsha 1
Dallas 1
Falls Church 1
Ferrara 1
Hangzhou 1
Kronberg 1
Los Angeles 1
Mountain View 1
Mumbai 1
Munich 1
New York 1
Norwalk 1
Olbia 1
Orange 1
Porto Alegre 1
Redwood City 1
San Jose 1
Sandston 1
Santeramo In Colle 1
Seattle 1
Totale 330
Nome #
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 54
Primary empty sella: Why and when to investigate hypothalamic-pituitary function. 46
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 44
Rare diseases in clinical endocrinology: A taxonomic classification system 38
Acromegaly is associated with increased cancer risk: A survey in Italy 37
Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database 31
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 29
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. 28
Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence 28
Correction to: Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database (Endocrine, (2018), 10.1007/s12020-018-1566-8) 27
Managing Cushing's disease: the state of the art. 26
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study 26
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 24
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients:a multicenter study. 21
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 20
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database 20
The role of somatostatin analogs in the management of immunoproliferative disease. 19
Long-term safety and efficacy of Omnitrope(®) in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study 17
Totale 535
Categoria #
all - tutte 3.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.091


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 0 0 0 0 9 18 3
2020/202124 0 2 4 4 2 2 1 0 3 3 3 0
2021/2022100 4 0 0 0 0 15 0 3 14 15 8 41
2022/2023102 20 4 0 5 12 7 0 11 17 12 9 5
2023/202465 6 19 5 4 2 2 0 4 2 1 14 6
2024/2025111 29 23 2 3 21 32 1 0 0 0 0 0
Totale 535